BRVE · Braveheart Bio, Inc.
Market Cap
$1.89B
Shares
70.65M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-07 | 2026-08-05 |
Showing 1–1 of 1 filings